The table below shows Cogent Biosciences, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
$7.87M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$269.78M
$232.66M
$173.75M
$121.63M
$55.91M
$25.74M
SG&A
$63.58M
COGT annual revenue (10-K history)
Cogent Biosciences, Inc. reported annual revenue of $7.87M for fiscal year 2020. That is down 65.0% from $22.50M in fiscal 2019. Figures come from the company's audited annual reports as filed with the SEC.